Monday, September 22, 2014

Top Asian Companies To Invest In 2014

U.S. stock futures were struggling to eke out gains Friday following Wall Street's big selloff in the prior session amid ongoing angst over tensions in Ukraine and economic weakness in China.

Ahead of the opening bell, Dow Jones industrial average index futures were unchanged. Standard & Poor's 500 index futures rose 0.1% and Nasdaq index futures added a similar amount.

The Dow has finished lower every day this week and is trying to avoid its first five-day weekly decline since May 2012.

Wall Street is also watching to see if the S&P 500 can regain the key 1850 level, which gave way in Thursday's 1.2% rout.

Asian stocks declined on lingering concerns about a slowdown in China and tensions in Ukraine ahead of a vote Sunday that could lead to Crimea breaking away from Ukraine and likely economic sanctions imposed against Russia.

Best Cheapest Stocks To Buy For 2015: CareFusion Corp (CFN)

CareFusion Corporation (CareFusion), incorporated on January 14, 2009, is a global medical technology company. The Company operates in two segments: Medical Systems and Procedural Solutions. The Medical Systems segment is organized around its medical equipment businesses. The Company�� Medical Systems segment�� business units and product lines include Infusion Systems, Dispensing Technologies, and Respiratory Technologies. The Procedural Solutions segment is organized around the Company�� disposable products and reusable surgical instruments businesses. The Company�� Procedural Solutions segment�� business units and product lines include Infection Prevention, Medical Specialties and Specialty Disposables. In August 2011, the Company acquired Rowa. In June 2012, the Company acquired U.K. Medical Limited. In July 2012, Natus Medical, Inc. acquired the Nicolet neurodiagnostic business from CareFusion. Effective December 31, 2013, CareFusion Corp acquired Vital Signs Inc from GE Healthcare, a unit of General Electric Co.

Medical Systems Segment

The Company�� develops, manufactures and markets capital equipment and related supplies for medication management, which includes its infusion and medication dispensing technologies, supply dispensing technologies and respiratory technologies. Its products are designed to enable healthcare professionals to improve patient safety by reducing medication errors and improving administrative controls, while simultaneously improving workflow and increasing operational efficiency. The Company sells these products primarily through its direct sales force, but use third-party distributors as well, particularly outside the United States. Many of its products in this segment are integrated with other information systems within the hospital, including financial and business systems that support patient admissions, discharges and transfers, operational systems that include inventory management and clinical systems that include pharmacy inf! ormation and electronic medical records.

The Company offers value-added services and programs, software technical services and clinical education, which are designed to enhance its customers��utilization of its medical equipment products. The Company�� project management, field service organization and customer call centers support its customers before, during and after product installation. The Company�� project management teams assist customers with the development of project implementation plans, which are designed to ensure rapid, seamless implementation of its products. The Company�� field service organization provides on-site expertise to resolve customers��service issues. The Company�� customer call centers provide additional support to its customers.

The Company is engaged in designing, developing and marketing of IV infusion systems that deliver medications and other fluids directly into a patient�� veins in precise, measured quantities over a range of infusion rates. The Company is provider of point-of-care systems that automate the dispensing of medications and supplies in hospitals and other healthcare facilities in the United States. The Company develops, manufactures, markets and services mechanical ventilators and associated consumables for patients with respiratory disorders.

The Company competes with Baxter International, B. Braun, Fresenius Kabi, Hospira, Omnicell, McKesson; Drager, and MAQUET.

Procedural Solutions Segment

The Procedural Solutions segment is organized around its disposable products and reusable surgical instruments businesses. In its Procedural Solutions segment, the Company develops, manufactures and markets single-use skin antiseptic and other patient-preparation products, non-dedicated IV infusion administration sets and accessories, reusable surgical instruments and non-dedicated ventilator circuits and other disposables used for providing respiratory therapy. The products in this segm! ent are u! sed in the operating room, interventional suites, and in the critical care departments of hospitals. The Company sells these products and services through a combination of direct sales representatives and third-party distributors.

The Company�� Infection Prevention business unit consists mainly of single-use medical products used in surgical and vascular access procedures, including skin preparation products and disposable IV infusion administration sets and accessories. The Company�� Medical Specialties business unit consists mainly of specialty medical devices used in delivering interventional care and reusable surgical instrumentation products. The Company�� Specialty Disposables business unit focuses on providing clinicians with respiratory consumable products that work either independently or in conjunction with its range of ventilators.

The Company competes with 3M, ICU Medical, Becton, Dickinson, Baxter International, B. Braun; Hospira; Smiths Medical; CR Bard, Integra Life Sciences, and Teleflex.

Advisors' Opinion:
  • [By Anna Prior]

    General Electric Co.(GE) agreed to sell the so-called Vital Signs segment of its health-care operation to CareFusion Corp.(CFN) (CFN) for $500 million.

Top Asian Companies To Invest In 2014: Inland Real Estate Corp (IRC)

Inland Real Estate Corporation is a self-managed, real estate investment trust (REIT). The Company owns and operates neighborhood, community, power and single tenant retail centers. It also may construct or develop properties or render services in connection with construction or development. As of December 31, 2011, the Company owned interests in 146 investment properties, including those owned through its unconsolidated joint ventures, which consist of 61 neighborhood retail centers totaling approximately 4,249,000 gross leasable square feet; 23 community centers totaling approximately 3,129,000 gross leasable square feet; 32 power centers totaling approximately 4,959,000 gross leasable square feet; one lifestyle center totaling approximately 561,000 gross leasable square feet, and 29 single-user properties totaling approximately 1,334,000 gross leasable square feet. In December 2012, the Company disposed two consolidated retail properties in the Greater Chicago and Indianapolis markets. In January 2013, the Company acquired for its consolidated portfolio Valparaiso Walk, a 137,509-square-foot power center in northwestern Indiana. In June 2013, Inland Real Estate Corp closed its acquisition of the 50% ownership interest of New York State Teachers Retirement System in the parties IN Retail Fund, L.L.C. (IN Retail) joint venture entity. In October 2013, Inland Real Estate Corporation announced that its joint venture with Dutch pension fund advisor PGGM has acquired Cedar Center South, a 139,000 square foot shopping center located in University Heights. In December 2013, Inland Real Estate Corp acquired two shopping centers in Florida and Arkansas.

In April 2012, it announced a joint venture acquisition with Inland Private Capital Corporation (IPCC) of two retail properties in Wisconsin. On March 6, 2012, it purchased for its own portfolio the Westgate Shopping Center, a grocery-anchored power center located in Fairview Park, Ohio. On February 29, 2012, the Company acquired the Stone Creek ! Towne Center, a power center located in the Cincinnati market. In March 2012, the Company acquired two retail properties in Ohio. On February 24, 2012, the Company�� joint venture with PGGM purchased Silver Lake Village. The property is located in St. Anthony, Minnesota. It also purchased Woodbury Commons located in Woodbury, Minnesota. On December 7, 2011, the Company�� joint venture with PGGM acquired Elston Plaza, a grocery-anchored center located in Chicago, Ill. On November 29, 2011, the Company purchased Brownstones Shopping Center, also grocery-anchored and located in Brookfield, Wis., a suburb of Milwaukee. In November 2011, the Company acquired Bradley Commons, an investment property.

The Company is engage in certain activities through Inland Venture Corporation (IVC) and Inland Exchange Venture Corporation (IEVC), wholly owned TRS entities. These entities engage in activities that would otherwise not be permitted for a REIT, such as managing properties owned by ventures, in which the Company is a partner. The Company owns interests in investment properties located in the States of California, Florida, Idaho, Illinois, Indiana, Michigan, Minnesota, Missouri, Nebraska, Ohio, Tennessee, and Wisconsin. On January 11, 2011, its joint venture with PGGM purchased Joffco Square from an unaffiliated third party. On February 14, 2011, the Company sold Schaumburg Golf Road Retail, in Schaumburg, Illinois to an unaffiliated third party.

Advisors' Opinion:
  • [By Rich Duprey]

    Midwest retail shopping center operator Inland Real Estate (NYSE: IRC  ) announced today that it set its monthly disbursement for August on its 8.125% Series A cumulative redeemable preferred stock at $0.169271 per share.

  • [By Dan Burrows]

    This is also a dividend stock you can count on. Even when earnings were volatile during the Ericsson partnership, STM still maintained its payout level. STM boasts a dividend yield north of 4%, though it hasn’t improved upon its nominal payout since 2011.

    Cheap Dividend Stocks #3: Inland Real Estate (IRC)

    Share Price as of 4/4: $10.67
    YTD Stock Performance: 1%
    Dividend Yield: 5.5%

  • [By Eric Volkman]

    Inland Real Estate (NYSE: IRC  ) is tapping the markets in order to win some new capital. The company announced the flotation of 9 million shares of its common stock in an underwritten public flotation. The price is $10.60 per share. Additionally, its underwriters have been granted a 30-day purchase option for up to an additional 1.35 million shares.

  • [By Rich Duprey]

    Midwest retail shopping center operator�Inland Real Estate (NYSE: IRC  ) announced today that it set its monthly disbursement for July on its 8.125% Series A cumulative redeemable preferred stock�at�$0.169271 per share.

Top Asian Companies To Invest In 2014: Biogen Idec Inc(BIIB)

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. Its marketed products include the AVONEX for the treatment of relapsing multiple sclerosis (MS); RITUXAN for treating relapsed or refractory, CD20-positive, and B-cell Non-Hodgkin?s lymphoma (NHL); TYSABRI to treat relapsing MS; FUMADERM for the treatment of severe plaque psoriasis in adult patients; and FAMPYRA, an oral compound for the improvement of walking in adult patients with MS with walking disability. Biogen Idec Inc.?s products under Phase III consist of PEGylated interferon beta-1a designed to prolong the effects and reduce the dosing frequency of interferon beta-1a; BG-12 for the treatment of MS; Daclizumab, a monoclonal antibody in relapsing MS; Long-lasting factor IX and VIII fusion protein for the treatment of hemophilia B; GA101, a monoclonal antibody for t he treatment of chronic lymphocytic leukemia and NHL; and Dexpramipexole, an orally administered small molecule for the treatment of amyotrophic lateral sclerosis. The company?s Phase I clinical trial products include Anti-LINGO for use in multiple sclerosis, Neublastin for use in neuropathic pain, CD40L for use in systemic lupus erythematosus, ANTI-TWAEK humanized monoclonal antibody for TWEAK, and BIIB037 for use in Alzheimer's disease; and Phase II clinical trial product comprises OCRELIZUMAB, a humanized monoclonal antibody for treating CD20. It has collaboration agreements with Genentech, Inc.; Elan Pharma International, Ltd; Acorda Therapeutics, Inc.; Portola Pharmaceuticals, Inc.; Swedish Orphan Biovitrum AB; Abbott Biotherapeutics Corp; and Vernalis plc. The company was formerly known as IDEC Pharmaceuticals Corporation and changed its name to Biogen Idec Inc. in November 2003. Biogen Idec Inc. was founded in 1985 and is headquartered in Weston, Massachusetts.

Advisors' Opinion:
  • [By Brian Orelli]

    Why the other big biotechs aren't dividend stocks
    True confession: I started this article with a plan to argue that the other three big biotechs -- Biogen Idec (NASDAQ: BIIB  ) , Celgene (NASDAQ: CELG  ) , and Gilead Sciences (NASDAQ: GILD  ) -- should also offer a dividend.

Top Asian Companies To Invest In 2014: Companhia de Bebidas das Americas - AmBev(ABV)

Companhia de Bebidas das Americas?Ambev engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt, and other non-alcoholic and non-carbonated products in the Americas. It also sells bottled water, isotonics, and ready-to-drink teas. The company provides its products under the brand names of Skol, Brahma, Antarctica, Guarana Antarctica, Gatorade, Brahva, Brahva Beats, Extra, Brahma Light, Brahma Ice, Quilmes, Stella Artois, Red Rock, Pepsi-Cola, Seven UP, Zenda, Concordia, Triple Kola, Quilmes Cristal, Brahma, Andes, Pacena, Taquina, Huari, Becker, Baltica, Pilsen, Patricia, Labatt Blue, Alexander Keith?s, and Kokanee. It has a licensing agreement with Anheuser-Busch, Inc. to produce, bottle, distribute, and sell Budweiser products in Canada and Paraguay. Companhia de Bebidas das Americas?Ambev distributes its products through direct distribution system and third-party distributors. The company was founded in 1888 and is headquarter ed in Sao Paulo, Brazil. Companhia de Bebidas das Americas?Ambev is a subsidiary of Interbrew International B.V.

Advisors' Opinion:
  • [By Hilary Kramer]

    Companhia de Bebidas das Americas (ABV): Better known as Ambev, it is one of the largest brewers in the world and the largest in Latin America (in terms of sales volume). It makes a variety of beverages, including beer and soft drinks, and is also one of the biggest independent PepsiCo bottlers in the world. The company has done a good job lately of emphasizing premium beers, which carry a higher margin, to offset recent lower sales volumes. ABV yields a solid 4.6%.

  • [By Dividend]

    Companhia de Bebidas Das Americas (ABV) has a market capitalization of $118.32 billion. The company employs 51,299 people, generates revenue of $14.120 billion and has a net income of $4.662 billion. Companhia de Bebidas Das Americas�� earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $6.829 billion. The EBITDA margin is 48.36 percent (the operating margin is 43.00 percent and the net profit margin 33.02 percent).

  • [By Robert Martin]

    South Africa, China, Mexico and Brazil collectively make up 68% of ECON�� holdings. The top three holdings are Naspers LTD (NPSNY) at 10%, AmBev (ABV) at 8% and FEMSA (FMX) at 5.6%.

Top Asian Companies To Invest In 2014: Grupo Casa Saba S.A. de C.V.(SAB)

Grupo Casa Saba, S.A.B. de C.V., through its subsidiaries, operates as a multi-channel and multi-product wholesale distributor primarily in Mexico. It distributes pharmaceutical products; health and beauty aids; publication products, such as magazines, books, albums, and stickers; food and non-perishable products; personal care and consumer goods; and general merchandise. The company also sells pharmaceutical products through its Farmacias ABC pharmacy chain located in Guadalajara, Jalisco; Farmacias Provee de Especialidades primarily located in Monterrey and Nuevo Leon of Mexico, as well as in the states of Chihuahua and Coahuila; and through Farmacias Benavides. In addition, it provides freight services to third parties. Further, it operates medical clinics; and offers specialized medical, rehabilitation, and surgical services, as well as provides real estate services. The company serves pharmacies, mass merchandisers, retail and convenience stores, specialty stores, sup ermarkets, and other specialized channels. As of December 31, 2010, it operated a distribution network consisting of 22 active distribution centers. It also operates in Brazil, Chile, and Peru. Grupo Casa Saba, S.A.B. de C.V. was founded in 1892 and is based in Mexico, Mexico.

Advisors' Opinion:
  • [By Tom Stoukas]

    SABMiller Plc (SAB) lost 2.1 percent to 3,462 pence. The world�� second-largest brewer said earnings before interest, taxes and amortization in the year to March 31 rose to $6.42 billion. That missed the median estimate of 13 analysts in a Bloomberg News survey that called for $6.46 billion.

  • [By Dividend Mantra]

    Altria Group, Inc. operates as a holding company with a number of subsidiaries, including Philip Morris USA Inc., U.S. Smokeless Tobacco Company LLC, John Middleton Co., Ste. Michelle Wine Estates Ltd. and Philip Morris Capital Corporation. They also hold approximately 26.9% of the economic and voting rights of SABMiller plc (SAB).

  • [By Sofia Horta e Costa]

    SABMiller Plc (SAB), the world�� second-biggest brewer, dropped 2.1 percent to 3,165 pence. Credit Suisse Group AG cut its rating on the beverage industry to benchmark, similar to neutral, from overweight, citing valuations. The Stoxx 600 Food & Beverage Index trades at 18.2 times projected earnings, compared with 14.3 times profit for the broader gauge, according to data compiled by Bloomberg.

  • [By Inyoung Hwang]

    U.K. stocks erased losses in the last half hour of trading, leaving the FTSE 100 Index (UKX) little changed, as a rally in British Sky Broadcasting Group Plc (BSY) and SABMiller Plc (SAB) offset Dagong Global Credit Rating Co.�� downgrade of U.S. sovereign debt.

Top Asian Companies To Invest In 2014: Legacy Reserves LP(LGCY)

Legacy Reserves LP, an independent oil and natural gas limited partnership, engages in the acquisition and development of oil and natural gas properties primarily located in the Permian Basin, Mid-Continent, and Rocky Mountain regions of the United States. As of December 31, 2010, it owned interests in producing oil and natural gas properties in 370 fields in the Permian Basin, Texas Panhandle, Wyoming, Oklahoma, and several other states; operated 2,132 gross productive wells; and owned non-operated interests in 3,227 gross productive wells, as well as had proved reserves of approximately 52.8 million barrels of crude oil equivalent. Legacy Reserves GP, LLC operates as the general partner of the partnership. Legacy Reserves LP was founded in 2005 and is headquartered in Midland, Texas.

Advisors' Opinion:
  • [By Matt DiLallo]

    Companies that hedge over the long-term can end up doing very well. This is really clearly seen when looking at an oil and gas MLP like Legacy Reserves (NASDAQ: LGCY  ) . The following chart does a great job of showing its annual revenues with and without the impact of its hedging program:

No comments:

Post a Comment